- Report
- May 2023
- 147 Pages
Global
From €4391EUR$4,949USD£3,801GBP
- Report
- April 2023
- 147 Pages
Global
From €4391EUR$4,949USD£3,801GBP
- Report
- April 2023
- 140 Pages
Global
From €4391EUR$4,949USD£3,801GBP
- Report
- December 2025
- 150 Pages
Germany
From €3416EUR$3,850USD£2,957GBP
€4303EUR$4,850USD£3,725GBP
- Report
- November 2025
- 150 Pages
India
From €3416EUR$3,850USD£2,957GBP
€4303EUR$4,850USD£3,725GBP
- Report
- November 2025
- 150 Pages
Japan
From €3416EUR$3,850USD£2,957GBP
€4303EUR$4,850USD£3,725GBP
- Report
- November 2025
- 150 Pages
China
From €3416EUR$3,850USD£2,957GBP
€4303EUR$4,850USD£3,725GBP
- Report
- January 2024
- 150 Pages
Global
From €3416EUR$3,850USD£2,957GBP
€4303EUR$4,850USD£3,725GBP
- Report
- October 2023
Global
From €3194EUR$3,600USD£2,765GBP
- Report
- October 2023
Asia Pacific
From €1331EUR$1,500USD£1,152GBP
- Report
- May 2023
- 75 Pages
Middle East, Africa
From €1331EUR$1,500USD£1,152GBP
- Report
- February 2023
- 158 Pages
Global
From €3194EUR$3,600USD£2,765GBP
- Report
- October 2025
- 88 Pages
Indonesia
From €4303EUR$4,850USD£3,725GBP
From €4303EUR$4,850USD£3,725GBP
- Report
- June 2025
- 70 Pages
From €3061EUR$3,450USD£2,650GBP
- Report
- June 2025
- 79 Pages
From €3061EUR$3,450USD£2,650GBP
- Report
- June 2025
- 77 Pages
Russia
From €2174EUR$2,450USD£1,882GBP
- Report
- June 2025
- 78 Pages
India
From €2174EUR$2,450USD£1,882GBP
- Report
- September 2024
- 111 Pages
Global
From €2618EUR$2,950USD£2,266GBP

The Family Planning market is an important part of Women's Health, providing access to contraception and other reproductive health services. It is a diverse market, with a range of products and services available to meet the needs of women of all ages. These include hormonal contraceptives, such as the pill and the patch, as well as long-acting reversible contraceptives, such as intrauterine devices and implants. Other services include counseling, education, and access to emergency contraception.
Family Planning services are essential for women to make informed decisions about their reproductive health, and to ensure that they have access to the resources they need to make those decisions. It is also important for reducing unintended pregnancies and promoting healthy pregnancies.
Some companies in the Family Planning market include Bayer, Merck, Pfizer, and Allergan. Show Less Read more